Yourgene Health PLC Director/PDMR Shareholding (8818R)
01 Noviembre 2019 - 1:00AM
UK Regulatory
TIDMYGEN
RNS Number : 8818R
Yourgene Health PLC
01 November 2019
Yourgene Health plc
("Yourgene Health" or the "Company")
Director / PDMR Shareholding
Manchester, UK - 1 November 2019: Yourgene Health (AIM: YGEN), a
leading international molecular diagnostics group, announces that
it was notified yesterday that Dr John Brown, Senior Independent
Director of the Company, purchased 100,000 ordinary shares of 0.10p
each in the Company yesterday at a price of 11.5 pence per ordinary
share, representing 0.02% of the Company's issued share capital,
via a pension fund held in his name.
Prior to the purchase, Dr John Brown did not hold any ordinary
shares nor options in the Company.
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014.
Yourgene Health plc Tel: +44 (0)161 667 1053
Lyn Rees, Chief Executive Officer investors@yourgene-health.com
Barry Hextall, Chief Financial Officer
Joanne Cross, Director of Marketing
Cairn Financial Advisers LLP (NOMAD) Tel: +44 (0)20 7213 0880
Liam Murray / James Caithie / Ludovico
Lazzaretti
Stifel Nicolaus Europe Limited (Sole Tel: +44 (0)20 7710 7600
Corporate Broker)
Nicholas Moore / Matthew Blawat / Ben
Maddison
Walbrook PR Ltd (Media and Investor Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com
Relations) Mob: 07980 541 893 / 07407 804 654
Lianne Cawthorne / Alice Woodings
About Yourgene Health
Yourgene Health is an international molecular diagnostics group
which develops and commercialises genetic products and services.
The group works in partnership with global leaders in DNA
technology to advance diagnostic science.
Yourgene develops and commercialises simple and accurate
molecular diagnostic solutions, primarily for reproductive health.
The Group's products include non-invasive prenatal tests (NIPT) for
Down's Syndrome and other genetic disorders, Cystic Fibrosis
screening tests, invasive rapid aneuploidy tests, male infertility
tests and genetic disease tests. Yourgene's commercial footprint is
already established in the UK, Europe, the Middle East, Africa and
Asia.
Our product development, research service and commercial
capabilities extend across the lifecycle of genetic test
development including regulatory submissions. Through our technical
expertise and partnerships, Yourgene Health is also extending its
genetic testing offering into oncology.
Yourgene Health is headquartered in Manchester, UK with offices
in Taipei and Singapore, and is listed on the London Stock
Exchange's AIM market under the ticker "YGEN". For more information
visit www.yourgene-health.com and follow us on twitter
@Yourgene_Health.
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
------ -------------------------------------------------------------------------------
a. Name Dr John Brown
-----------------------------------
2 Reason for notification
------------------------------------------ -----------------------------------
a. Position/Status Senior Independent Director
------------------------------------------ -----------------------------------
b. Initial notification/ Initial notification
Amendment
-----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a. Name Yourgene Health plc
------------------------------------------
b. LEI 213800UUIT8BZE7QEH33
------------------------------------------ -----------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
------ -------------------------------------------------------------------------------
a. Description of Ordinary shares of 0.1p each
the financial
instrument, type ISIN: GB00BN31ZD89
of instrument
Identification
Code
------------------------------------------ -----------------------------------
b. Nature of the Purchase
transaction
------------------------------------------ -----------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
------------------------------------------ ---------------
11.5p 100,000
--------------- --------------
e. Date of the transaction 31 October 2019
------------------------------------------ -----------------------------------
f. Place of the transaction UK
------------------------------------------ -----------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHDFLFXKBFBFBV
(END) Dow Jones Newswires
November 01, 2019 03:00 ET (07:00 GMT)
Yourgene Health (LSE:YGEN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Yourgene Health (LSE:YGEN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024